Original Biomedicals Co (ROCO:6483) Marketable Securities: NT$10.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6483 Original Biomedicals Co Ltd ROCO:6483
38 GF Score
Price NT$13.60
! 3 Warning Signs
View Full Analysis

What is Original Biomedicals Co Marketable Securities?

Original Biomedicals Co ROCO:6483 -1.09% 38 Marketable Securities is NT$10.00 Mil as of Jun. 2026. GuruFocus rates ROCO:6483 with a GF Score™ of 38/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Original Biomedicals Co's Marketable Securities for the quarter that ended in Jun. 2026 was NT$10.00 Mil.

Original Biomedicals Co's annual Marketable Securities declined from Dec. 2023 (NT$99.80 Mil) to Dec. 2024 (NT$89.74 Mil) and declined from Dec. 2024 (NT$89.74 Mil) to Dec. 2025 (NT$9.99 Mil).

Original Biomedicals Co  (ROCO:6483) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Original Biomedicals Co Marketable Securities Related Terms

Original Biomedicals Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Original Biomedicals Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Original Biomedicals Co Marketable Securities Chart

Original Biomedicals Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only 156.02 34.93 99.80 89.74 9.99

Original Biomedicals Co Semi-Annual Data
Dec11 Dec12 Dec13 Jun14 Dec14 Jun15 Dec15 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 109.70 89.74 89.83 9.99 10.00
ROCO:6483
38GF Score
Original Biomedicals Co Ltd ROCO:6483
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Original Biomedicals Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$10.00 Mil mean?
Original Biomedicals Co (ROCO:6483) has a Marketable Securities of NT$10.00 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Original Biomedicals Co and its competitors.
Is Original Biomedicals Co's Marketable Securities too high?
Original Biomedicals Co's current Marketable Securities is NT$10.00 Mil. Overall, Original Biomedicals Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Original Biomedicals Co's Marketable Securities compare to ZTS?
Original Biomedicals Co's Marketable Securities of NT$10.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Original Biomedicals Co and its competitors. Original Biomedicals Co's current Marketable Securities is NT$10.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Original Biomedicals Co stock overvalued right now?
Original Biomedicals Co (ROCO:6483) has a current Marketable Securities of NT$10.00 Mil. The current Marketable Securities is NT$10.00 Mil. Original Biomedicals Co's overall GF Score™ is 38/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Original Biomedicals Co (ROCO:6483), the current Marketable Securities is NT$10.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Original Biomedicals Co Business Description

Address No. 9, Nanke 2nd Road, 2 Floor-1, Xinshi District, Tainan, TWN, 74147
Original Biomedicals Co Ltd is a biopharmaceutical company engaged in the research and development of drugs. The company focuses on developing new drug formulations, drug delivery systems, and repurposing existing pharmaceutical products.
38GF Score

Get the complete analysis for ROCO:6483

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$13.60
Price